The company formerly known as CELLINK Life Sciences builds a portfolio that blends biology, engineering and computer science technologies
A researcher at Olathe, KS, startup Ronawk uses CELLINK’s Lumen X™ bioprinter, powered by Volumetric, to mass produce adult stem cells. While CELLINK’s name remains for the bioprinting business, the parent company has been rebranded as BICO Group—short for “bioconvergence,” the combination of biology, engineering and computer science technologies—including robotics, artificial intelligence, advanced genomics and bioprinting—for healthcare and life-sci applications. [BICO Group]
The Swedish company that commercialized the first bio-based ink in 2016 has moved far beyond bioprinting and on-demand biofabrication of human organs and tissues, after completing six acquisitions of companies in other life-sciences specialties this year thus far. CELLINK Life Sciences has been renamed BICO Group. BICO is short for “bioconvergence,” the combination of biology, engineering and computer science technologies for healthcare and life-sci applications . . .
